Her parents were supportive and hired an instructor. In November 2023, after hundreds of hours of training and after ...

Zanubrutinib shows sustained efficacy and safety in relapsed/refractory CLL, with a median progression-free survival of 52.5 months in long-term follow-up.

Olympic gold medalist gymnast Simone Biles showed off her game day fit on the field before the Packers-Bears game.

Zanubrutinib and venetoclax combination shows an 87% 36-month PFS rate in CLL/SLL patients, regardless of del (17p)/TP53 or IGHV status. The SEQUOIA trial demonstrates durable minimal residual disease ...

Samantha Fulnecky's mother Kristi served a three-year stint on the Springfield City Council where she was embroiled with ...

Among patients who were newly diagnosed with multiple myeloma, Kyprolis (carfilzomib) plus Revlimid (lenalidomide) and dexamethasone (KRd) was associated with improvements in progression-free survival ...

A food program meant to help hungry students in Parkland County, just west of Edmonton, has received a major funding boost. A ...

KRd significantly prolonged progression-free survival and improved the MRD negativity rate compared to VRd in newly diagnosed multiple myeloma.

A new phase 2 clinical trial suggests that a chemotherapy-free, minimal residual disease (MRD)–driven treatment strategy may offer durable remissions and the possibility of time-limited therapy for ...

Much of the opposition to standardized tests stems not from the idea that they don’t work but from the realization that they ...

We know plastic is bad for the environment. So why is pollution spiking in Lake Erie? The Wake Up for Wednesday, Dec. 3, 2025 ...